Skip to main content
. 2023 Apr 17;23:57. doi: 10.1186/s12880-023-00999-3

Table 2.

The tumour B-mode、RTE、CDFI ultrasound features per molecular subtype

Molecular Subtype Total [n = 85] Luminal A [n = 36]
VS. Other Types
Luminal B [n = 20]
VS. Other Types
HER2+ [n = 16]
VS. Other Types
TNBC [n = 13]
VS. Other Types
N Luminal A p Luminal B p HER2 p TNBC p
Tumor size (cm, Mean ± SD) 2.33 ± 1.14 1.72 ± 0.73 2.61 ± 1.23 3.09 ± 1.19 2.67 ± 1.14
Shape 0.516 0.730 0.115 0.362
Oval/Round 11(12.9) 6(16.7) 2(10.0) 0(0.0) 3(23.1)
Irregular 74(87.1) 30(83.3) 18(90.0) 16(100) 10(76.9)
Orientation 0.014 1.000 0.111 0.198
Parallel 73(85.9) 27(75.0) 17(85.0) 16(100) 13(100)
Non-parallel 12(14.1) 9(25.0) 3(15.0) 0(0.0) 0(0.0)
Margin 0.022 0.330 0.024 0.682
Circumscribed 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Microlobulated 8(9.4) 1(2.8) 1(5.0) 5(31.2) 1(7.7)
Spiculated 24(28.2) 16(44.4) 3(15.0) 3(18.8) 2(15.4)
Angular 41(48.3) 15(41.7) 12(60.0) 6(37.5) 8(61.5)
Indistinct 12(14.1) 4(11.1) 4(20.0) 2(12.5) 2(15.4)
Echo pattern 0.105 1.000 0.003 1.000
Hyperechoic 3(3.5) 2(5.6) 0(0.0) 1(6.3) 0(0.0)
Isoechoic 5(5.9) 0(0.0) 1(5.0) 4(25.0) 0(0.0)
Hypoechoic 77(90.6) 34(94.4) 19(95.0) 11(68.7) 13(100)
Posterior features 0.330 1.000 0.338 0.115
No posterior features 49(57.6) 21(58.3) 12(60.0) 8(50.0) 8(61.5)
Combined pattern 6(7.1) 1(2.8) 1(5.0) 2(12.5) 2(15.4)
Enhancement 2(2.4) 0(0.0) 0(0.0) 1(6.3) 1(7.7)
Shadowing 28(32.9) 14(38.9) 7(35.0) 5(31.2) 2(15.4)
Calcifications 0.004 0.051 0.180 1.000
No 28(32.9) 18(50.0) 3(15.0) 3(18.8) 4(30.8)
Yes 57(67.1) 18(50.0) 17(85.0) 13(81.2) 9(69.2)
RTE 0.001 0.003 0.280 0.339
 1 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 2 44(51.8) 8(22.2) 13(65.0) 12(75.0) 11(84.6)
 3 6(7.1) 1(2.8) 4(20.0) 1(6.3) 0(0.0)
 4 19(22.3) 13(36.1) 3(15.0) 2(12.5) 1(7.7)
 5 16(18.8) 14(38.9) 0(0.0) 1(6.3) 1(7.7)
CDFI 0.004 0.097 0.039 0.007
 0 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 1 11(13.0) 9(25.0) 2(10.0) 0(0.0) 0(0.0)
 2 42(49.4) 19(52.8) 14(70.0) 6(37.5) 3(23.1)
 3 32(37.6) 8(22.2) 4(20.0) 10(62.5) 10(76.9)